meto
Mechanism

Antagonist

A molecule that binds a receptor and blocks its activation — used therapeutically to silence an over-active signalling pathway.

Definition

An antagonist binds a receptor without activating it, preventing the endogenous ligand from binding and blocking downstream signalling. Antagonists feature more prominently in small-molecule drug design (beta-blockers, antihistamines) than in peptide therapeutics, which tend to mimic rather than block native signals.

$149 panel.
A clinician reads it in 24 hours.

Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.